The sharp improvement in Adjusted EBITDA and services margin signals that the operating leverage thesis is playing out. Monitor the next 10-Q for continued margin expansion and cash flow generation, as the company is still burning cash ($492K operating cash outflow) but moving toward sustained profitability.
Price Chart
Executive Summary
Champions Oncology reported Q1 FY2027 revenue of $15.2M, up 8.8% YoY, with oncology services margin improving to 51% from 43% and Adjusted EBITDA surging to $671K from $59K. The company remains unprofitable on a GAAP basis (net loss of $426K), but the operating leverage story is strengthening as revenue growth and margin expansion drive a sharp improvement in cash-adjusted profitability. The sequential improvement from the prior quarter's $574K Adjusted EBITDA on $16.6M revenue suggests the business is scaling efficiently despite lumpy quarterly revenue.
Key Financial Metrics
Key Facts
- Revenue of $15.2M, up 8.8% YoY from $14.0M
- Oncology services margin improved to 51% from 43% in the prior-year period
- Adjusted EBITDA increased to $671K from $59K YoY
- GAAP net loss narrowed to $426K from $466K YoY
- Cash and cash equivalents of $4.4M with no debt
- Cost of oncology revenue decreased 5.8% YoY to $7.5M
Financial Impact
Revenue up 8.8% YoY; Adjusted EBITDA up 11.4x YoY to $671K; oncology services margin +800bps YoY to 51%
Risk Factors
- Cash burn continues ($492K operating cash outflow) with cash declining to $4.4M
- Sales & marketing spend increased 66.6% YoY, pressuring near-term profitability
- Revenue remains lumpy due to study timing and milestone conversion
- Small market cap ($70M) limits institutional interest and liquidity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-061383 |
| Document: csbr-20260910.htm | 0001628280-26-061383 |
| Document: 0001628280-26-061383-index-headers.html | 0001628280-26-061383 |
| Document: 0001628280-26-061383-index.html | 0001628280-26-061383 |
| Document: 0001628280-26-061383.txt | 0001628280-26-061383 |
| 8-K Data (Synthetic) | 0001628280-26-061383 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $5.10 $4.84 | ▼ −5.10% | ▼ −6.97% | $4.91 (−3.73%) |
Aug 28, 2026 8w ago | DEFA14A | $4.93 $4.93 | · 0.00% | ▼ −0.26% | $4.91 (−0.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers